Stockreport

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the year ended December 31, 2023. “We are very excited abo [Read more]